Please enable JavaScript to continue using this application.

Compare $EVMN vs $STRO | Chartloom

Compare

$EVMN vs $STRO

Evommune Inc · Sutro Biopharma Inc

EVMN

Evommune Inc

STRO

Sutro Biopharma Inc

Compare $EVMN vs $STRO

Comparing Evommune Inc and Sutro Biopharma Inc

EVMNEvommune Inc

STROSutro Biopharma Inc

EVMNEvommune Inc

Market cap

$225M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.9%

52W performance

-69.1%

FCF yield

-55.4%

STROSutro Biopharma Inc

Market cap

$236M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.01x

Rev growth (TTM)

-56.3%

YTD performance

30.2%

52W performance

67.2%

FCF yield

-61.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EVMN

STRO

Detailed metrics comparison

EVMN

Evommune Inc

STRO

Sutro Biopharma Inc

Market Cap

EVMN$225M

STRO$236M

Enterprise Value

EVMN$166M

STRO$421M

Price

EVMN$6.25

STRO$14.27

P/E Ratio

EVMNN/A

STRON/A

P/S Ratio

EVMN14.07x

STRO5.17x

EV/Sales

EVMN10.38x

STRO9.22x

EV/EBITDA

EVMN0.00x

STRO0.00x

P/B Ratio

EVMN0.90x

STRO5.78x

P/FCF Ratio

EVMNN/A

STRON/A

EV/FCF

EVMN-1.33x

STRO-2.89x

PEG Ratio

EVMNN/A

STRON/A

Forward P/E (NTM)

EVMNN/A

STRON/A

Forward P/S (NTM)

EVMNN/A

STRO6.01x

Revenue (TTM)

EVMN$16M

STRO$46M

Revenue Growth (YoY)

EVMNN/A

STRO-56.3%

Forward Rev Growth

EVMN881.5%

STRO-19.2%

Gross Margin (TTM)

EVMN0.0%

STRO0.0%

Operating Margin (TTM)

EVMN0.0%

STRO0.0%

EBITDA Margin (TTM)

EVMN-1097.9%

STRO-275.3%

Net Margin (TTM)

EVMN-943.2%

STRO-395.2%

FCF Margin (TTM)

EVMN-779.8%

STRO-318.6%

Net Income (TTM)

EVMN$-151M

STRO$-181M

FCF (TTM)

EVMN$-125M

STRO$-146M

EPS (TTM)

EVMN-$4.18

STRO-$10.90

ROE (TTM)

EVMN-4676.0%

STRO-22384.0%

ROA (TTM)

EVMN-4337.0%

STRO-8812.0%

ROIC (TTM)

EVMN-4661.0%

STRO-22384.0%

Cash

EVMN$60M

STRO$54M

Debt

EVMN$952K

STRO$239M

Net Cash/Debt

EVMN$59M

STRO$-185M

Current Ratio (TTM)

EVMN11.68x

STRO3.32x

Quick Ratio (TTM)

EVMN11.48x

STRO3.22x

Debt/Equity (TTM)

EVMN0.00x

STRO4.05x

Debt/Assets (TTM)

EVMN0.0%

STRO0.0%

Interest Coverage (TTM)

EVMNN/A

STRON/A

Net Debt/EBITDA (TTM)

EVMN0.00x

STRO0.00x

Beta

EVMN0.62

STRO1.47

52W Performance

EVMN-69.1%

STRO67.2%

YTD Performance

EVMN-63.9%

STRO30.2%

% from 52W High

EVMN-81.2%

STRO-67.5%

% from 52W Low

EVMN3.8%

STRO99.6%

Asset Turnover (TTM)

EVMN0.00x

STRO0.22x

FCF Yield (TTM)

EVMN-55.4%

STRO-61.6%

Earnings Yield (TTM)

EVMN-67.0%

STRO-76.4%

Dividend Yield (TTM)

EVMNN/A

STRON/A

Rule of 40

EVMN-779.8

STRO-374.9

EV/GP/RG

EVMNN/A

STRON/A

Ticker research

View EVMN research View STRO research

Metric	EVMN Evommune Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$225M	$236M
Enterprise Value	$166M	$421M
Price	$6.25	$14.27
P/E Ratio	N/A	N/A
P/S Ratio	14.07x	5.17x
EV/Sales	10.38x	9.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.01x
Revenue & Growth
Revenue (TTM)	$16M	$46M
Revenue Growth (YoY)	N/A	-56.3%
Forward Rev Growth	881.5%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1097.9%	-275.3%
Net Margin (TTM)	-943.2%	-395.2%
FCF Margin (TTM)	-779.8%	-318.6%
Net Income (TTM)	$-151M	$-181M
FCF (TTM)	$-125M	$-146M
EPS (TTM)	-$4.18	-$10.90
ROE (TTM)	-4676.0%	-22384.0%
ROA (TTM)	-4337.0%	-8812.0%
ROIC (TTM)	-4661.0%	-22384.0%
Financial Health
Cash	$60M	$54M
Debt	$952K	$239M
Net Cash/Debt	$59M	$-185M
Current Ratio (TTM)	11.68x	3.32x
Quick Ratio (TTM)	11.48x	3.22x
Debt/Equity (TTM)	0.00x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.47
52W Performance	-69.1%	67.2%
YTD Performance	-63.9%	30.2%
% from 52W High	-81.2%	-67.5%
% from 52W Low	3.8%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.22x
FCF Yield (TTM)	-55.4%	-61.6%
Earnings Yield (TTM)	-67.0%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-779.8	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View EVMN research	View STRO research

Valuation

P/S Ratio

STRO

5.17x

EVMN

14.07x

EV/FCF

STRO

-2.89x

EVMN

-1.33x

Growth & revenue

Revenue Growth TTM

STRO

-56.3%

Forward Revenue Growth

EVMN

881.5%

STRO

-19.2%

Profitability & performance

Gross Margin

EVMN

0.0%

STRO

0.0%

ROE

EVMN

-4676.0%

STRO

-22384.0%

FCF Yield %

EVMN

-55.4%

STRO

-61.6%

52-Week Performance

STRO

67.2%

EVMN

-69.1%

Detailed metrics comparison

EVMN

Evommune Inc

STRO

Sutro Biopharma Inc

Market Cap

EVMN$225M

STRO$236M

Enterprise Value

EVMN$166M

STRO$421M

Price

EVMN$6.25

STRO$14.27

P/E Ratio

EVMNN/A

STRON/A

P/S Ratio

EVMN14.07x

STRO5.17x

EV/Sales

EVMN10.38x

STRO9.22x

EV/EBITDA

EVMN0.00x

STRO0.00x

P/B Ratio

EVMN0.90x

STRO5.78x

P/FCF Ratio

EVMNN/A

STRON/A

EV/FCF

EVMN-1.33x

STRO-2.89x

PEG Ratio

EVMNN/A

STRON/A

Forward P/E (NTM)

EVMNN/A

STRON/A

Forward P/S (NTM)

EVMNN/A

STRO6.01x

Revenue (TTM)

EVMN$16M

STRO$46M

Revenue Growth (YoY)

EVMNN/A

STRO-56.3%

Forward Rev Growth

EVMN881.5%

STRO-19.2%

Gross Margin (TTM)

EVMN0.0%

STRO0.0%

Operating Margin (TTM)

EVMN0.0%

STRO0.0%

EBITDA Margin (TTM)

EVMN-1097.9%

STRO-275.3%

Net Margin (TTM)

EVMN-943.2%

STRO-395.2%

FCF Margin (TTM)

EVMN-779.8%

STRO-318.6%

Net Income (TTM)

EVMN$-151M

STRO$-181M

FCF (TTM)

EVMN$-125M

STRO$-146M

EPS (TTM)

EVMN-$4.18

STRO-$10.90

ROE (TTM)

EVMN-4676.0%

STRO-22384.0%

ROA (TTM)

EVMN-4337.0%

STRO-8812.0%

ROIC (TTM)

EVMN-4661.0%

STRO-22384.0%

Cash

EVMN$60M

STRO$54M

Debt

EVMN$952K

STRO$239M

Net Cash/Debt

EVMN$59M

STRO$-185M

Current Ratio (TTM)

EVMN11.68x

STRO3.32x

Quick Ratio (TTM)

EVMN11.48x

STRO3.22x

Debt/Equity (TTM)

EVMN0.00x

STRO4.05x

Debt/Assets (TTM)

EVMN0.0%

STRO0.0%

Interest Coverage (TTM)

EVMNN/A

STRON/A

Net Debt/EBITDA (TTM)

EVMN0.00x

STRO0.00x

Beta

EVMN0.62

STRO1.47

52W Performance

EVMN-69.1%

STRO67.2%

YTD Performance

EVMN-63.9%

STRO30.2%

% from 52W High

EVMN-81.2%

STRO-67.5%

% from 52W Low

EVMN3.8%

STRO99.6%

Asset Turnover (TTM)

EVMN0.00x

STRO0.22x

FCF Yield (TTM)

EVMN-55.4%

STRO-61.6%

Earnings Yield (TTM)

EVMN-67.0%

STRO-76.4%

Dividend Yield (TTM)

EVMNN/A

STRON/A

Rule of 40

EVMN-779.8

STRO-374.9

EV/GP/RG

EVMNN/A

STRON/A

Ticker research

View EVMN research View STRO research

Metric	EVMN Evommune Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$225M	$236M
Enterprise Value	$166M	$421M
Price	$6.25	$14.27
P/E Ratio	N/A	N/A
P/S Ratio	14.07x	5.17x
EV/Sales	10.38x	9.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.90x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.01x
Revenue & Growth
Revenue (TTM)	$16M	$46M
Revenue Growth (YoY)	N/A	-56.3%
Forward Rev Growth	881.5%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1097.9%	-275.3%
Net Margin (TTM)	-943.2%	-395.2%
FCF Margin (TTM)	-779.8%	-318.6%
Net Income (TTM)	$-151M	$-181M
FCF (TTM)	$-125M	$-146M
EPS (TTM)	-$4.18	-$10.90
ROE (TTM)	-4676.0%	-22384.0%
ROA (TTM)	-4337.0%	-8812.0%
ROIC (TTM)	-4661.0%	-22384.0%
Financial Health
Cash	$60M	$54M
Debt	$952K	$239M
Net Cash/Debt	$59M	$-185M
Current Ratio (TTM)	11.68x	3.32x
Quick Ratio (TTM)	11.48x	3.22x
Debt/Equity (TTM)	0.00x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	1.47
52W Performance	-69.1%	67.2%
YTD Performance	-63.9%	30.2%
% from 52W High	-81.2%	-67.5%
% from 52W Low	3.8%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.22x
FCF Yield (TTM)	-55.4%	-61.6%
Earnings Yield (TTM)	-67.0%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-779.8	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View EVMN research	View STRO research